Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula

Core Points - The U.S. Government budget for Fiscal Year 2026 has been passed, ending the government shutdown, which is a significant development for the company [1] - The new budget includes provisions that expedite the FDA pathway for innovative, non-soy, plant-based infant nutrition, aligning with the company's focus on whole-food, plant-based nutrition [1] Company Impact - Else Nutrition Holdings Inc. is recognized as a global pioneer in whole-food, plant-based nutrition for various age groups, including babies and toddlers, positioning the company favorably in the market following the budget agreement [1] - The passage of the budget is expected to enhance the company's operational capabilities and market opportunities in the infant nutrition sector [1]